Jon Hadad

About the Author Jon Hadad

Jon Hadad graduated from the University of Delaware with a degree in political science. Prior to joining the Smarter Analyst team, he was an industry analyst at a New York research firm.

Analyst Scales Back Target on Advanced Micro Device (AMD) Stock Amid Lower CPU Demand

While excitement is building for Advanced Micro Device’s (AMD) 2019 release of its new 7-nanometer processing chip and the company is rumored to …

Oracle’s (ORCL) Flat Revenue Keeps This Top Analyst Sidelined on the Stock

2018 has been a disappointing year for Oracle (ORCL) investors. While database and cloud rivals, including Amazon and Microsoft, have seen their stocks …

Apple (AAPL) Losing Its Edge? This Analyst Concerned About Sluggish Xr Sales

As part of its fourth-quarter earnings update early last month, Apple (AAPL) announced it would stop releasing unit sales data for iPhone, iPad …

Nvidia (NVDA) Stock: Short-Term Pain to Give Way to Long-Term Gains

Rumours are swirling over of Softbank’s potential sale of its Nvidia (NVDA) stake, and investors are taking notice. Nothing has been confirmed yet, …

Micron (MU) Stock’s Upside Trimmed by Lower Component Demand, Says Analyst

Micron Technology (MU) is due to release its Q1F19 financial results next week, but analysts are already adjusting their expectations downward. For one, …

Top Analyst Bullish on Advanced Micro Devices (AMD) Stock and Its New 7-nm Chips

Among techies, investors and analysts, there is excitement building around Advanced Micro Devices’ (AMD) impending launch of its new 7-nanometer (7nm) processing chips. …

Qualcomm’s (QCOM) Win Could Lead to Favorable Settlement With Apple (AAPL), Says Analyst

On Monday, a Chinese court approved US chipmaker Qualcomm’s (QCOM) request for an injunction against Apple (AAPL), which now faces a ban on …

This Analyst Optimistic for Apple (AAPL) Stock After US-China Trade Truce

Apple (AAPL) investors can breathe a (temporary) sigh of relief. Last week, US president Donald Trump and China president Xi Jinping agreed to …

Cartel Investigation Drags Teva Pharmaceutical (TEVA) Stock Down; Evercore Weighs In

Israeli generic drug manufacturer Teva (TEVA) was named by the Washington Post as being one of more than a dozen subjects of a …

Hexindai (HX) Stock Skyrockets on Strategic Investment News

Chinese consumer lending company Hexindai (HX) announced a strategic investment in what it only describes as a “target company” that is well-known in …